INVESTIGATION INTO THE POTENTIAL FOR IONTOPHORESIS FACILITATED TRANSDERMAL DELIVERY OF ACYCLOVIR

被引:18
作者
LASHMAR, UT
MANGER, J
机构
[1] Pharmaceutical Development Laboratories, The Wellcome Foundation Plc, Dartford
关键词
IONTOPHORESIS; ELECTROTRANSPORT; TRANSDERMAL DRUG DELIVERY; PENETRATION ENHANCER; SODIUM LAURYL SULFATE; CETRIMIDE; DRUG DELIVERY; ACYCLOVIR;
D O I
10.1016/0378-5173(94)90403-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The potential for iontophoresis facilitated transdermal transport of acyclovir alone or in combination with a cationic or anionic penetration enhancer (cetrimide or sodium lauryl sulphate respectively) was investigated in the neutral range of the drug (pH 6-8). The amount of drug permeated in vitro across nude mouse skin by means of passive diffusion was low (2.5 mu g/cm(2), 90 min). With iontophoresis treatment the permeation was 3-fold greater than that of passive diffusion when a negative charge was applied to the drug solution, possibly due to some ionisation of the drug. Applying a positive charge increased the iontophoretic permeation slightly over that of passive diffusion due to volume flow. The addition of varying amounts of sodium lauryl sulphate or cetrimide to the donor additionally increased the iontophoretic permeation. A positive donor side was less effective compared with a negative donor mainly due to polarisation during anodal delivery. Cetrimide caused an up to 3-fold higher cathodal permeation of acyclovir compared to sodium lauryl sulphate, largely due to the difference in molecular weight/volume of the permeating ions, but also due to other effects. The increase in permeation with increasing enhancer concentration leveled off at a certain point for both enhancers, possibly due to a change in the zeta potential of the skin.
引用
收藏
页码:73 / 82
页数:10
相关论文
共 53 条
[1]  
ALN HA, 1993, J CONTROL RELEASE, V25, P205
[2]  
ASHTON P, 1987, Journal of Pharmacy and Pharmacology, V39, p25P
[3]   ENHANCEMENT OF NALOXONE PENETRATION THROUGH HUMAN-SKIN INVITRO USING FATTY-ACIDS, FATTY ALCOHOLS, SURFACTANTS, SULFOXIDES AND AMIDES [J].
AUNGST, BJ ;
ROGERS, NJ ;
SHEFTER, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :225-234
[4]  
BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6
[5]  
Barry B.W., 1983, DERMATOLOGICAL FORMU, P95
[6]   ENHANCED PERCUTANEOUS-ABSORPTION VIA IONTOPHORESIS .1. EVALUATION OF AN INVITRO SYSTEM AND TRANSPORT OF MODEL COMPOUNDS [J].
BELLANTONE, NH ;
RIM, S ;
FRANCOEUR, ML ;
RASADI, B .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 30 (01) :63-72
[7]   COMPARISON BETWEEN THE IONTOPHORETIC AND PASSIVE TRANSPORT OF THYROTROPIN-RELEASING-HORMONE ACROSS EXCISED NUDE-MOUSE SKIN [J].
BURNETTE, RR ;
MARRERO, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (08) :738-743
[8]   CHARACTERIZATION OF THE PORE TRANSPORT-PROPERTIES AND TISSUE ALTERATION OF EXCISED HUMAN-SKIN DURING IONTOPHORESIS [J].
BURNETTE, RR ;
ONGPIPATTANAKUL, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (02) :132-137
[9]   CHARACTERIZATION OF THE PERMSELECTIVE PROPERTIES OF EXCISED HUMAN-SKIN DURING IONTOPHORESIS [J].
BURNETTE, RR ;
ONGPIPATTANAKUL, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (10) :765-773
[10]   DIRECT-CURRENT IONTOPHORETIC TRANSDERMAL DELIVERY OF PEPTIDE AND PROTEIN DRUGS [J].
CHIEN, YW ;
SIDDIQUI, O ;
SHI, WM ;
LELAWONGS, P ;
LIU, JC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (05) :376-383